Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Obesity Reports
Erschienen in: Current Obesity Reports 3/2019

03.05.2019 | Obesity Treatment (CM Apovian, Section Editor)

Severe Obesity in the Pediatric Population: Current Concepts in Clinical Care

verfasst von: Claudia K. Fox, Amy C. Gross, Eric M. Bomberg, Justin R. Ryder, Megan M. Oberle, Carolyn T. Bramante, Aaron S. Kelly

Erschienen in: Current Obesity Reports | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This review describes (1) the clinical assessment of pediatric patients with severe obesity, including a summary of salient biological, psychological, and social factors that may be contributing to the patient’s obesity and (2) the current state of treatment strategies for pediatric severe obesity, including lifestyle modification therapy, pharmacotherapy, and metabolic and bariatric surgery.

Recent Findings

Lifestyle modification therapy alone is insufficient for achieving clinically significant BMI reduction for most youth with severe obesity and metabolic and bariatric surgery, though effective and durable, is not a scalable treatment strategy. Pharmacological agents in the pipeline may 1 day fill this gap in treatment.

Summary

Treatment of severe pediatric obesity requires a chronic care management approach utilizing multidisciplinary teams of health care providers and multi-pronged therapies.
Literatur
1.
Ogden CL, Carroll MD, Lawman HG, Fryar CD, Kruszon-Moran D, Kit BK, et al. Trends in obesity prevalence among children and adolescents in the United States, 1988-1994 through 2013-2014. JAMA. 2016;315(21):2292–9.CrossRefPubMedPubMedCentral
2.
• Kelly AS, Barlow SE, Rao G, Inge TH, Hayman LL, Steinberger J, et al. Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the American Heart Association. Circulation. 2013;128(15):1689–712. This review summarizes the defintions, epidemiology and short- and long-term risks of severe pediatric obesity. CrossRefPubMed
3.
• Grossman D, Bibbins-Domingo K, Curry SJ, et al. Screening for Obesity in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA. 2017;317(23):2417–26. USPSTF reviewed studies that measured outcomes of interventions for pediatric obesity and found that comprehensive, intensive behavioral interventions (≥26 contact hours) in children and adolescents 6 years and older with obesity can result in improvements in weight status for up to 12 months. CrossRefPubMed
4.
Sharma AM, Padwal R. Obesity is a sign - over-eating is a symptom: an aetiological framework for the assessment and management of obesity. Obes Rev. 2010;11(5):362–70.CrossRefPubMed
5.
Min J, Chiu DT, Wang Y. Variation in the heritability of body mass index based on diverse twin studies: a systematic review. Obes Rev. 2013;14(11):871–82.CrossRefPubMedPubMedCentral
6.
7.
Farooqi IS, O'Rahilly S. Mutations in ligands and receptors of the leptin-melanocortin pathway that lead to obesity. Nat Clin Pract Endocrinol Metab. 2008;4(10):569–77.CrossRefPubMed
8.
Chen KY, Muniyappa R, Abel BS, Mullins KP, Staker P, Brychta RJ, et al. RM-493, a melanocortin-4 receptor (MC4R) agonist, increases resting energy expenditure in obese individuals. J Clin Endocrinol Metab. 2015;100(4):1639–45.CrossRefPubMedPubMedCentral
9.
Gross AC, Fox CK, Rudser KD, Foy AM, Kelly AS. Eating behaviours are different in youth with obesity and severe obesity. Clin Obes. 2016;6(1):68–72.CrossRefPubMed
10.
St-Onge MP. Sleep-obesity relation: underlying mechanisms and consequences for treatment. Obes Rev. 2017;18(Suppl 1):34–9.CrossRefPubMed
11.
Geiker NRW, Astrup A, Hjorth MF, Sjodin A, Pijls L, Markus CR. Does stress influence sleep patterns, food intake, weight gain, abdominal obesity and weight loss interventions and vice versa? Obes Rev. 2018;19(1):81–97.CrossRefPubMed
12.
Puder JJ, Munsch S. Psychological correlates of childhood obesity. Int J Obes. 2010;34(Suppl 2):S37–43.CrossRef
13.
Fox CK, Gross AC, Rudser KD, Foy AM, Kelly AS. Depression, anxiety, and severity of obesity in adolescents: is emotional eating the link? Clin Pediatr (Phila). 2016;55(12):1120–5.CrossRef
14.
Bauer KW, Marcus MD, Larson N, Neumark-Sztainer D. Socioenvironmental, personal, and behavioral correlates of severe obesity among an ethnically/racially diverse sample of US adolescents. Child Obes. 2017;13(6):470–8.CrossRefPubMedPubMedCentral
15.
Small L, Aplasca A. Child obesity and mental health: a complex interaction. Child Adolesc Psychiatr Clin N Am. 2016;25(2):269–82.CrossRefPubMed
16.
Davis L, Barnes AJ, Gross AC, Ryder JR, Shlafer RJ. Adverse childhood experiences and weight status among adolescents. J Pediatr. 2019;204:71–6 e71.CrossRefPubMed
17.
Kaur J, Lamb MM, Ogden CL. The association between food insecurity and obesity in children-the National Health and nutrition examination survey. J Acad Nutr Diet. 2015;115(5):751–8.CrossRefPubMed
18.
Gundersen C, Lohman BJ, Garasky S, Stewart S, Eisenmann J. Food security, maternal stressors, and overweight among low-income US children: results from the National Health and nutrition examination survey (1999-2002). Pediatrics. 2008;122(3):e529–40.CrossRefPubMed
19.
Larson N, Story M. Food insecurity and weight status among US children and families: a review of the literature. Am J Prev Med. 2011;40(2):166–73.CrossRefPubMed
20.
Larson N, Story M, Nelson M. Neighborhood environments: disparities in access to healthy foods in the US. Am J Prev Med. 2009;36(1):74–81.CrossRefPubMed
21.
Stephens L, McNaughton S, Crawford D, Ball K. Predictors of high-energy foods and beverages: a longitudinal study among socio-economically disadvantaged adolescents. Public Health Nutr. 2014;17(2):324–37.CrossRefPubMed
22.
Kral T, Chittams J, Moore R. Relationship betwen food insecurity, child weight status, and parent-reported child eating and snacking behaviors. J Spec Pediatr Nurs. 2017;22(2):1–11.
23.
Tomayko E, Mosso K, Cronin K, et al. Household food insecurity and dietary patterns in rural and urban American Indian families with young children. BMC Public Health. 2017;17(1):611–21.CrossRefPubMedPubMedCentral
24.
Eicher-Miller H, Zhao Y. Evidence for the age-specific relationship of food insecurity and key dietary outcomes among US children and adolescents. Nutr Res Rev. 2018;31:98–113.CrossRefPubMed
25.
Wilde P, Ranney C. The monthly food stamp cycle: shopping frequency and food intake decisions in an endogenous switching regression framework. Am J Agric Econ. 2000;82(1):200–13.CrossRef
26.
Dinour L, Bergen D, Yeh M. The food insecurity-obesity paradox: a review of the literature and the role food stamps may play. J Am Diet Assoc. 2007;107(11):1952–61.CrossRefPubMed
27.
• Inge TH, Jenkins TM, Zeller M, Dolan L, Daniels SR, Garcia VF, et al. Baseline BMI is a strong predictor of nadir BMI after adolescent gastric bypass. J Pediatr. 2010;156(1):103–108.e101. A longitudinal assessment of 61 adolescents who underwent laparoscopic Roux-en-Y gastric bypass at a single pediatric center showed a decrease in BMI of approximately 37% in all patients, regardless of starting BMI, 1 year after surgery. CrossRefPubMedPubMedCentral
28.
Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467–84; discussion 484-465.PubMedPubMedCentral
29.
• Gross A, Kaizer A, Kelly AS, et al. Long and Short of It: Early Response Predicts Longer-term Outcomes in Pediatric Weight Management. Obesity. 2019;27(2):272–9 Among 687 children treated in multicomponent pediatric weight management clinics across the U.S., those who achieved 3% BMI reduction at 1-month compared to those who did not achieve this early success were 5 times more likely to also have BMI reduction at 12 months. CrossRefPubMed
30.
Danielsson P, Kowalski J, Ekblom O, Marcus C. Response of severely obese children and adolescents to behavioral treatment. Arch Pediatr Adolesc Med. 2012;166(12):1103–8.
31.
Kalarchian MA, Levine MD, Arslanian SA, Ewing LJ, Houck PR, Cheng Y, et al. Family-based treatment of severe pediatric obesity: randomized, controlled trial. Pediatrics. 2009;124(4):1060–8.CrossRefPubMedPubMedCentral
32.
Johnston CA, Tyler C, Palcic JL, Stansberry SA, Gallagher MR, Foreyt JP. Smaller weight changes in standardized body mass index in response to treatment as weight classification increases. J Pediatr. 2011;158(4):624–7.CrossRefPubMed
33.
Kelly KP, Kirschenbaum DS. Immersion treatment of childhood and adolescent obesity: the first review of a promising intervention. Obes Rev. 2011;12(1):37–49.CrossRefPubMed
34.
Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Obesity Society. J Am Coll Cardiol. 2014;63(25 Pt B):2985–3023.CrossRefPubMed
35.
Gardner CD, Trepanowski JF, Del Gobbo LC, et al. Effect of low-fat vs low-carbohydrate diet on 12-month weight loss in overweight adults and the association with genotype pattern or insulin secretion: the DIETFITS randomized clinical trial. JAMA. 2018;319(7):667–79.CrossRefPubMedPubMedCentral
36.
Bailes JR, Strow MT, Werthammer J, McGinnis RA, Elitsur Y. Effect of low-carbohydrate, unlimited calorie diet on the treatment of childhood obesity: a prospective controlled study. Metab Syndr Relat Disord. 2003;1(3):221–5.CrossRefPubMed
37.
Berkowitz RI, Wadden TA, Gehrman CA, Bishop-Gilyard CT, Moore RH, Womble LG, et al. Meal replacements in the treatment of adolescent obesity: a randomized controlled trial. Obesity. 2011;19(6):1193–9.CrossRefPubMed
38.
Sothern, Udall JN, Jr., Suskind RM, Vargas A, Blecker U. Weight loss and growth velocity in obese children after very low calorie diet, exercise, and behavior modification Acta Paediatr (Oslo, Norway : 1992) 2000;89(9):1036–1043.
39.
Bakhach M, Shah V, Harwood T, et al. The protein-sparing modified fast diet: an effective and safe approach to induce rapid weight loss in severely obese adolescents. Global pediatric health. 2016;3:2333794x15623245.CrossRefPubMedPubMedCentral
40.
41.
Wu L, Sun S, He Y, Jiang B. The effect of interventions targeting screen time reduction: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95(27):e4029.CrossRef
42.
Wickham EP, 3rd, DeBoer MD. Evaluation and treatment of severe obesity in childhood. Clin Pediatr 2015;54(10):929–940.
43.
Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, weight watchers, and zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005;293(1):43–53.CrossRefPubMed
44.
Wing RR, Venditti E, Jakicic JM, Polley BA, Lang W. Lifestyle intervention in overweight individuals with a family history of diabetes. Diabetes Care. 1998;21(3):350–9.CrossRefPubMed
45.
Foright RM, Presby DM, Sherk VD, Kahn D, Checkley LA, Giles ED, et al. Is regular exercise an effective strategy for weight loss maintenance? Physiol Behav. 2018;188:86–93.CrossRefPubMedPubMedCentral
46.
Jull A, Chen R. Parent-only vs. parent-child (family-focused) approaches for weight loss in obese and overweight children: a systematic review and meta-analysis. Obes Rev. 2013;14(9):761–8.CrossRefPubMed
47.
Buttitta M, Iliescu C, Rousseau A, Guerrien A. Quality of life in overweight and obese children and adolescents: a literature review. Qual Life Res. 2014;23(4):1117–39.CrossRefPubMed
48.
•• Srivastava G, Fox CK, Kelly AS, et al. Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity. Obesity (Silver Spring). 2019;27(2):190–204. This expert consensus statement describes the indications for the use of pharmacotherapy for pediatric obesity. CrossRef
49.
Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA. 2005;293(23):2873–83.CrossRefPubMed
50.
Ryder JR, Kaizer A, Rudser KD, Gross A, Kelly AS, Fox CK. Effect of phentermine on weight reduction in a pediatric weight management clinic. Int J Obes. 2017;41(1):90–3.CrossRef
51.
Sherafat-Kazemzadeh R, Yanovski SZ, Yanovski JA. Pharmacotherapy for childhood obesity: present and future prospects. Int J Obes (2005). 2013;37(1):1–15.
52.
Kelly AS, Fox CK, Rudser KD, Gross AC, Ryder JR. Pediatric obesity pharmacotherapy: current state of the field, review of the literature and clinical trial considerations. Int J Obes. 2016;40(7):1043–50.CrossRef
53.
•• Ryder JR, Fox CK, Kelly AS. Treatment Options for Severe Obesity in the Pediatric Population: Current Limitations and Future Opportunities. Obesity (Silver Spring). 2018;26(6):951–60. This review describes the current state and future directions of obesity pharmacotherapy and metabolic and bariatric surgery for the pediatric population. CrossRef
54.
Fox CK, Kelly AS. The potential role of combination pharmacotherapy to improve outcomes of pediatric obesity: a case report and discussion. Front Pediatr. 2018;6:361.CrossRefPubMedPubMedCentral
55.
Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, et al. Association of Pharmacological Treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016;315(22):2424–34.CrossRefPubMedPubMedCentral
56.
O'Neil PM, Birkenfeld AL, McGowan B, Mosenzon O, Pedersen SD, Wharton S, et al. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet. 2018;392(10148):637–49.CrossRefPubMed
57.
•• Pratt JSA, Browne A, Browne NT, et al. ASMBS pediatric metabolic and bariatric surgery guidelines, 2018. SOARD. 2018;14(7):882–901 This review describes recommendations for metabolic and bariatric surgery for the pediatric population based on updated outomes of longitudinal studies.
58.
Inge TH, Courcoulas AP, Jenkins TM, Michalsky MP, Helmrath MA, Brandt ML, et al. Weight loss and health status 3 years after bariatric surgery in adolescents. N Engl J Med. 2016;374(2):113–23.CrossRefPubMed
59.
• Inge TH, Jenkins TM, Xanthakos SA, Dixon JB, Daniels SR, Zeller MH, et al. Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis. Lancet Diabetes Endo. 2017;5(3):165–73. A prospective follow-up analysis of 58 adolescents undergoing roux-en-Y gastric bypass found a mean BMI reduction of 29% at 8 years with accompanying improvements in hypertenstion, dyslipidemia, and type 2 diabetes.
60.
Olbers T, Beamish AJ, Gronowitz E, Flodmark CE, Dahlgren J, Bruze G, et al. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study. Lancet Diabetes Endo. 2017;5(3):174–83.
61.
Ryder JR, Gross AC, Fox CK, et al. Factors associated with long-term weight loss maintenance following bariatric surgery in adolescents with severe obesity. Int J Obes. 2018;42(1):102–107.
62.
Beamish AJ, Olbers T, Kelly AS, Inge TH. Cardiovascular effects of bariatric surgery. Nat Rev Cardiol. 2016;13(12):730–43.CrossRefPubMed
63.
Ryder JR, Edwards NM, Gupta R, Khoury J, Jenkins TM, Bout-Tabaku S, et al. Changes in functional mobility and musculoskeletal pain after bariatric surgery in teens with severe obesity: teen-longitudinal assessment of bariatric surgery (LABS) study. JAMA Pediatr. 2016;170(9):871–7.CrossRefPubMedPubMedCentral
64.
Kelly AS, Ryder JR, Marlatt KL, Rudser KD, Jenkins T, Inge TH. Changes in inflammation, oxidative stress, and adipokines following bariatric surgery among adolescents with severe obesity. Int J Obes. 2016;40(2):275-80.
65.
Inge TH, Prigeon RL, Elder DA, Jenkins TM, Cohen RM, Xanthakos SA, et al. Insulin sensitivity and beta-cell function improve after gastric bypass in severely obese adolescents. J Pediatr. 2015;167(5):1042–1048.e1041.CrossRefPubMedPubMedCentral
66.
Nehus EJ, Khoury JC, Inge TH, Xiao N, Jenkins TM, Moxey-Mims MM, et al. Kidney outcomes three years after bariatric surgery in severely obese adolescents. Kidney Int. 2017;91(2):451–8.CrossRefPubMed
67.
Manco M, Mosca A, De Peppo F, et al. The benefit of sleeve gastrectomy in obese adolescents on nonalcoholic steatohepatitis and hepatic fibrosis. J Pediatr. 2017;180:31–7 e32.CrossRefPubMed
68.
Nobili V, Carpino G, De Peppo F, et al. Laparoscopic sleeve gastrectomy improves nonalcoholic fatty liver disease-related liver damage in adolescents by reshaping cellular interactions and hepatic Adipocytokine production. J Pediatr. 2017.
69.
Sarwer DB, Dilks RJ, Spitzer JC, et al. Changes in dietary intake and eating behavior in adolescents after bariatric surgery: an ancillary study to the teen-LABS consortium. Obes Surg. 2017;27(12):3082–91.PubMedPubMedCentral
70.
Zeller MH, Pendery EC, Reiter-Purtill J, et al. From adolescence to young adulthood: trajectories of psychosocial health following Roux-en-Y gastric bypass. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.. 2017;13(7):1196–203.
71.
Zeller MH, Pendery EC, Reiter-Purtill J, Hunsaker SL, Jenkins TM, Helmrath MA, et al. From adolescence to young adulthood: trajectories of psychosocial health following Roux-en-Y gastric bypass. SOARD : official journal of the American Society for Bariatric Surgery. 2017;13(7):1196–203.
72.
Purnell JQ, Selzer F, Wahed AS, Pender J, Pories W, Pomp A, et al. Type 2 diabetes remission rates after laparoscopic gastric bypass and gastric banding: results of the longitudinal assessment of bariatric surgery study. Diabetes Care. 2016;39(7):1101–7.CrossRefPubMedPubMedCentral
73.
Kadera BE, Lum K, Grant J, Pryor AD, Portenier DD, DeMaria EJ. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss. SOARD : official journal of the American Society for Bariatric Surgery. 2009;5(3):305–9.
74.
Wang G-F, Yan Y-X, Xu N, Yin D, Hui Y, Zhang JP, et al. Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis. Obes Surg. 2015;25(2):199–208.CrossRefPubMed
75.
Zeitler P, Hirst K, Pyle L, et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366(24):2247–56.CrossRefPubMed
76.
Courcoulas AP, King WC, Belle SH, et al. Seven-year weight trajectories and health outcomes in the longitudinal assessment of bariatric surgery (labs) study. JAMA Surgery. 2018;153(5):427–34.
77.
Hatoum IJ, Blackstone R, Hunter TD, Francis DM, Steinbuch M, Harris JL, et al. Clinical factors associated with remission of obesity-related comorbidities after bariatric surgery. JAMA Surgery. 2016;151(2):130–7.CrossRefPubMed
78.
Benaiges D, Sague M, Flores-Le Roux JA, et al. Predictors of hypertension remission and recurrence after bariatric surgery. Am J Hypertens. 2016;29(5):653–9.CrossRefPubMed
79.
Staalesen T, Olbers T, Dahlgren J, Fagevik Olsén M, Flodmark CE, Marcus C, et al. Development of excess skin and request for body-contouring surgery in postbariatric adolescents. Plast Reconstr Surg. 2014;134(4):627–36.CrossRefPubMed
80.
Zeller MH, Inge TH, Modi AC, Jenkins TM, Michalsky MP, Helmrath M, et al. Severe obesity and comorbid condition impact on the weight-related quality of life of the adolescent patient. J Pediatr. 2015;166(3):651–9 e654.CrossRefPubMed
81.
Zeller MH, Washington GA, Mitchell JE, Sarwer DB, Reiter-Purtill J, Jenkins TM, et al. Alcohol use risk in adolescents 2 years after bariatric surgery. SOARD : official journal of the American Society for Bariatric Surgery. 2017;13(1):85–94.
82.
Goldschmidt AB, Khoury J, Jenkins TM, Bond DS, Thomas JG, Utzinger LM, et al. Adolescent loss-of-control eating and weight loss maintenance after bariatric surgery. Pediatrics. 2018;141(1):e20171659.CrossRefPubMedPubMedCentral
83.
Phillips CM. Metabolically healthy obesity across the life course: epidemiology, determinants, and implications. Ann N Y Acad Sci. 2017;1391(1):85–100.CrossRefPubMed
84.
• Ryder JR, Kaizer AM, Jenkins TM, Kelly AS, Inge TH, Shaibi GQ. Heterogeneity in Response to Treatment of Adolescents with Severe Obesity: The Need for Precision Obesity Medicine. Obesity (Silver Spring). 2019;27(2):288–94. Outcomes data from three centers across the United States conducting either lifestyle, pharmacotherapy, or metabolic and bariatric surgery interventions for pediatric severe obesity were pooled. Change in BMI following interventions ranged from -50.2% to +12.9%, with each intervention (lifestyle [range: -25.4% to 5.0%], pharmacotherapy [range: -10.8% to 12.9%], and metabolic and bariatric surgery [range: -50.2% to -13.3%]) exhibiting wide individual variation in response. CrossRef
85.
Braet C. Patient characteristics as predictors of weight loss after an obesity treatment for children. Obesity (Silver Spring). 2006;14(1):148–55.CrossRef
86.
Di Stefano G, Bini V, Papi F, et al. Leptin serum concentrations predict the responsiveness of obese children and adolescents to weight excess reduction program. Int J Obes Relat Metab Disord. 2000;24(12):1586–91.CrossRefPubMed
87.
Nathan BM, Rudser KD, Abuzzahab MJ, Fox CK, Coombes BJ, Bomberg EM, et al. Predictors of weight-loss response with glucagon-like peptide-1 receptor agonist treatment among adolescents with severe obesity. Clin Obes. 2016;6(1):73–8.CrossRefPubMed
88.
Love-Osborne K, Sheeder J, Zeitler P. Addition of metformin to a lifestyle modification program in adolescents with insulin resistance. J Pediatr. 2008;152(6):817–22.CrossRefPubMedPubMedCentral
89.
Ryder JR, Gross AC, Fox CK, Kaizer AM, Rudser KD, Jenkins TM, et al. Factors associated with long-term weight-loss maintenance following bariatric surgery in adolescents with severe obesity. Int J Obes. 2018;42(1):102–7.CrossRef
Metadaten
Titel
Severe Obesity in the Pediatric Population: Current Concepts in Clinical Care
verfasst von
Claudia K. Fox
Amy C. Gross
Eric M. Bomberg
Justin R. Ryder
Megan M. Oberle
Carolyn T. Bramante
Aaron S. Kelly
Publikationsdatum
03.05.2019
Verlag
Springer US
Erschienen in
Current Obesity Reports / Ausgabe 3/2019
Elektronische ISSN: 2162-4968
DOI
https://doi.org/10.1007/s13679-019-00347-z

Weitere Artikel der Ausgabe 3/2019

Current Obesity Reports 3/2019 Zur Ausgabe

Obesity Treatment (CM Apovian, Section Editor)

Lessons Learned from the POUNDS Lost Study: Genetic, Metabolic, and Behavioral Factors Affecting Changes in Body Weight, Body Composition, and Cardiometabolic Risk

Metabolism (M Dalamaga, Section Editor)

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives

Obesity Treatment (CM Apovian, Section Editor)

Gut Microbiota Dysbiosis in Human Obesity: Impact of Bariatric Surgery

Obesity Treatment (CM Apovian, Section Editor)

Nonalcoholic Fatty Liver Disease and Obesity Treatment

Health Services and Programs (R Welbourn and CM Borg, Section Editors)

How Group-Based Interventions Can Improve Services for People with Severe Obesity

Obesity Treatment (CM Apovian, Section Editor)

Extrinsic and Intrinsic Immunometabolism Converge: Perspectives on Future Research and Therapeutic Development for Obesity

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise